Annual Report 2009 of Beximco Pharmaceuticals Limited

It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of 2009. Sales revenue in the year crossed BDT 4.86 billion with a robust growth of more than 21%. The Company achieved export sales of Taka. 272.13 million in 2009 as against Taka. 170.60 million of 2008- representing a commendable 59.5% growth. The pre-tax profit increased by 21.47% to Taka. 867.47 million from Taka. 714.12 million in the previous year. EPS also increased to Tk. 4.13 from Tk. 3.61, a 14.4% increase on a comparable basis. The Company successfully raised Taka. 4,100 million through the issuance of 41 million fully convertible, six months, 5% dividend preference shares.

The Board of Directors has recommended 15% stock dividend for approval of the shareholders for the year ended 31^st December 2009. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Beximco Pharmaceuticals Limited :